EcoDrugPlus

Histone Deacetylase 3

Ensembl ID : ENSMOCG00000000336
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSMOCG00000005287
Gene Symbol: HDAC4
3 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSMOCG00000000884
Gene Symbol: HDAC5
3 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSMOCG00000022461
Gene Symbol: HDAC6
3 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSMOCG00000019731
Gene Symbol: HDAC7
3 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSMOCG00000019902
Gene Symbol: HDAC8
3 Cross references
201 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSMOCG00000002700
Gene Symbol: HCAR2
1 Cross references
165 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSMOCG00000002294
Gene Symbol: HSD11B1
3 Cross references
248 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSMOCG00000020737
Gene Symbol: HCN4
3 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSMOCG00000015876
Gene Symbol: HCRTR1
3 Cross references
96 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSMOCG00000014320
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSMOCG00000000284
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).